Machine-assisted Portuguese translation is in progress. This page is shown in English pending professional review.

Capabilities

What We Do

Mac-Chem manufactures active pharmaceutical ingredients across three segments, Oncology API, Lyophilized Bulk Sterile API, and General API, from a single CGMP-compliant plant in Boisar, Maharashtra.

Oncology API 15,000 kg/yr · Lyophilized Bulk Sterile API 15,000 kg/yr · General API 10,000 kg/yr installed capacity

Installed capacity

Three API segments, one Boisar site

Installed annual capacity across Mac-Chem's three API segments, as published in the company's own capacity register.

Product mix

What the plant actually produces

Mac-Chem's 63-product API catalog spans oncology and non-oncology therapeutic areas, backed by DMF and CEP dossiers. Every count below is drawn live from the product catalog.

Therapeutic area Products Share of catalog
Oncology 33 52%
Anti-infective 9 14%
Anesthesia 9 14%
Supportive care 6 10%
Hormonal 5 8%
Other therapeutic area 1 2%
Total catalog 63 100%

Source: API catalog (63 products, live count). Every ingredient also carries a regulatory filing (DMF / CEP). See API Products for the filterable catalog.

By capability

Four ways into the plant

Manufacturing is the base capability everything else builds on; lyophilization is the specialization behind Mac-Chem's Lyophilized Bulk Sterile API segment; R&D covers the non-infringing process development behind the catalog and its pipeline. Quality & Regulatory governs what the plant is permitted to ship, and where.